Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950149-06-000580
Filing Date
2006-12-14
Accepted
2006-12-14 13:10:17
Documents
3
Effectiveness Date
2006-12-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT - ADDITIONAL MATERIALS f25837defa14a.htm DEFA14A 25387
2 GRAPHIC f25837f2583702.gif GRAPHIC 919
3 GRAPHIC f25837f2583701.gif GRAPHIC 1640
  Complete submission text file 0000950149-06-000580.txt   30755
Mailing Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107
Business Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107 4155127624
SIRNA THERAPEUTICS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-27914 | Film No.: 061276327
SIC: 2834 Pharmaceutical Preparations